COVID-SEROINDEX
DEAD

Serial Number

90089958

Owner

Kantaro Biosciences LLC

Attorney

Michelle A. Cooke

Filing Date

Aug 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

COVID-SEROINDEX Trademark

Serial Number: 90089958

COVID-SEROINDEX is a trademark filed by Kantaro Biosciences LLC on August 3, 2020. The trademark is classified under Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Kantaro Biosciences LLC (13 trademarks)

1460 Broadway
New York, NY 10036

Entity Type: 16

Trademark Details

Filing Date

August 3, 2020

Registration Date

Not Registered

Goods & Services

Medical diagnostic apparatus for testing for viruses; Blood testing apparatus; Medical apparatus for collecting, processing and testing blood, bodily fluids, biological and cellular samples and specimens; Medical diagnostic instruments for the analysis of blood, body fluids, biological and cellular samples and specimens; Medical apparatus for analysis of biological materials, namely, blood, serum, plasma, bodily fluids, biological and cellular samples and specimens, for medical and clinical purposes; Medical apparatus and instruments for laboratory analysis, clinical diagnosis and treatment of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Tools and devices for medical diagnostics for detecting, measuring and analyzing DNA, RNA, genetic material, antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Medical apparatus, instruments and devices for diagnostic use, namely, apparatus for medical diagnostic testing and analysis in the fields of infectious, viral, communicable, blood-borne pathogen, vector-borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Medical test kits consisting primarily of probes, assays, reagents, media, solutions, buffers, antibodies, antigens, control materials, membranes, plasma, diagnostic chemicals, calibrators, swabs for medical purposes, plates, vessels, tubes, pipettes, trays, panels, slides, cards and bottles for testing for the presence of antibodies in blood, biological fluids, bodily fluids, biological and cellular samples and specimens and tissue; Medical diagnostic apparatus and devices for detecting, testing and analyzing blood, serum, plasma, bodily fluids, biological and cellular samples and specimens for DNA, RNA, genetic material, antibodies, enzymes, antigens, diseases, viruses and infections, all related to SARS-CoV-2 and COVID-19; Medical diagnostic apparatus for detecting infection; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Biological sample containers for medical purposes, sold empty, namely, containers for the collection and preservation and transport of blood, biofluids, bodily fluids, biological and cellular samples and specimens obtained from humans and animals; all the foregoing related to the detection, diagnosis, testing, prevention and/or treatment of SARS-CoV-2, COVID-19 and antibodies, antigens, diseases, illnesses, viruses, disorders and/or infections related to SARS-CoV-2 or COVID-19

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 31, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 31, 2022 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 14, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 14, 2021 GNFR
FINAL REFUSAL WRITTEN
Nov 14, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 20, 2021 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 26, 2021 GNRN
NON-FINAL ACTION E-MAILED
Feb 26, 2021 GNRT
NON-FINAL ACTION WRITTEN
Feb 26, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 2, 2020 NWOS
NEW APPLICATION ENTERED
Aug 6, 2020 NWAP